These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32218533)

  • 1. High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumors.
    Shirai R; Osumi T; Terashima K; Kiyotani C; Uchiyama M; Tsujimoto S; Yoshida M; Yoshida K; Uchiyama T; Tomizawa D; Shioda Y; Sekiguchi M; Watanabe K; Keino D; Ueno-Yokohata H; Ohki K; Takita J; Ito S; Deguchi T; Kiyokawa N; Ogiwara H; Hishiki T; Ogawa S; Okita H; Matsumoto K; Yoshioka T; Kato M
    Eur J Hum Genet; 2020 Aug; 28(8):1124-1128. PubMed ID: 32218533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism.
    Gigante L; Paganini I; Frontali M; Ciabattoni S; Sangiuolo FC; Papi L
    Fam Cancer; 2016 Jan; 15(1):123-6. PubMed ID: 26342593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.
    Foulkes WD; Kamihara J; Evans DGR; Brugières L; Bourdeaut F; Molenaar JJ; Walsh MF; Brodeur GM; Diller L
    Clin Cancer Res; 2017 Jun; 23(12):e62-e67. PubMed ID: 28620006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutional balanced translocations involving SMARCB1: A rare cause of rhabdoid tumor predisposition syndrome.
    Blackburn PR; McGee RB; Mostafavi R; Carroll AJ; Mikhail FM; Armstrong GT; Furtado LV; Chiang J; Wheeler DA; Carey SS; Nichols KE; Upadhyaya SA
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23195. PubMed ID: 37548271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor.
    Fukushima H; Yamasaki K; Sakaida M; Tsujio N; Okuno T; Ishii N; Okada K; Fujisaki H; Matsusaka Y; Sakamoto H; Yoneda A; Hara J; Inoue T
    Pathol Int; 2021 Feb; 71(2):155-160. PubMed ID: 33378586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two molecularly distinct atypical teratoid/rhabdoid tumors (or tumor components) occurring in an infant with rhabdoid tumor predisposition syndrome 1.
    Thomas C; Knerlich-Lukoschus F; Reinhard H; Johann PD; Sturm D; Sahm F; Bens S; Vogt J; Nemes K; Oyen F; Kordes U; Siebert R; Schneppenheim R; Messing-Jünger M; Pietsch T; von Deimling A; Paulus W; Pfister SM; Kool M; Frühwald MC; Hasselblatt M
    Acta Neuropathol; 2019 May; 137(5):847-850. PubMed ID: 30945057
    [No Abstract]   [Full Text] [Related]  

  • 7. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.
    Eaton KW; Tooke LS; Wainwright LM; Judkins AR; Biegel JA
    Pediatr Blood Cancer; 2011 Jan; 56(1):7-15. PubMed ID: 21108436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells.
    Darr J; Klochendler A; Isaac S; Geiger T; Eden A
    Mol Cancer; 2015 Sep; 14():167. PubMed ID: 26370283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelioid Sarcoma Arising in a Long-Term Survivor of an Atypical Teratoid/Rhabdoid Tumor in a Patient With Rhabdoid Tumor Predisposition Syndrome.
    Baker TG; Lyons MJ; Leddy L; Parham DM; Welsh CT
    Pediatr Dev Pathol; 2021; 24(2):164-168. PubMed ID: 33470921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
    Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M
    Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology and diagnosis of SMARCB1-deficient tumors.
    Margol AS; Judkins AR
    Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional chondrosarcoma in a survivor of rhabdoid tumor: enlarging the spectrum of tumors associated with SMARCB1 germline mutations.
    Forest F; David A; Arrufat S; Pierron G; Ranchere-Vince D; Stephan JL; Clemenson A; Delattre O; Bourdeaut F
    Am J Surg Pathol; 2012 Dec; 36(12):1892-6. PubMed ID: 23154773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
    Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
    Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor.
    Thomas C; Oehl-Huber K; Bens S; Soschinski P; Koch A; Nemes K; Oyen F; Kordes U; Kool M; Frühwald MC; Hasselblatt M; Siebert R
    Genes Chromosomes Cancer; 2021 Aug; 60(8):586-590. PubMed ID: 33896072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development.
    Vitte J; Gao F; Coppola G; Judkins AR; Giovannini M
    Nat Commun; 2017 Aug; 8(1):300. PubMed ID: 28824165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion.
    Bosse KR; Shukla AR; Pawel B; Chikwava KR; Santi M; Tooke L; Castagna K; Biegel JA; Bagatell R
    Cancer Genet; 2014 Sep; 207(9):415-9. PubMed ID: 25018128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent myeloid sarcoma, atypical teratoid/rhabdoid tumor, and hypereosinophilia in an infant with a germline SMARCB1 mutation.
    Metts JL; Park SI; Soares BP; Fong C; Biegel JA; Goldsmith KC
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28111898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent breakpoints of focal deletion and uniparental disomy in 22q11.1 or 11.2 segmental duplication region reveal distinct tumorigenesis in rhabdoid tumor of the kidney.
    Haruta M; Arai Y; Okita H; Tanaka Y; Takimoto T; Kamijo T; Oue T; Souzaki R; Taguchi T; Kuwahara Y; Chin M; Nakadate H; Hiyama E; Ishida Y; Koshinaga T; Kaneko Y
    Genes Chromosomes Cancer; 2021 Aug; 60(8):546-558. PubMed ID: 33896058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors.
    Savla J; Chen TT; Schneider NR; Timmons CF; Delattre O; Tomlinson GE
    J Natl Cancer Inst; 2000 Apr; 92(8):648-50. PubMed ID: 10772683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.